Polydox (PolyMVA) has not been shown to treat or prevent cancer, lupus, asthma, HIV, or any other medical condition.
Polydox is a product that contains lipoic acid, acetylcysteine, palladium, B vitamins, and other ingredients. The inventor and promoters of Polydox make many claims for this product that are not supported by any scientific evidence. Some of the components of Polydox are antioxidants (alpha-lipoic acid and acetylcysteine ).
Polydox is a synthetic product containing lipoic acid-palladium complex (LAPd) and B complex vitamins. Patients use it to treat cancer, HIV/AIDS, chronic fatigue syndrome, psoriasis, and other degenerative disorders. Studies done in animals indicate that Polydox has neuroprotective (3), radioproctective (4), antidiabetic (7) and antioxidant (5)(6) properties.
Polydox has not been evaluated in clinical trials.
The inventor of Polydox claims that it is a metalo-vitamin with antioxidant activity capable of repairing damaged genes. Polydox is said to have DNA reductase and electro-active properties that alter electron flow in cancer cells at the mitochondrial level, resulting in cytotoxicity.
The manufacturer reports benefits for cancer patients such as increases in energy and appetite, and reduction in cancer-related pain (1)(2). However, no independent scientific data support these claims.
Studies in rats show palladium-alpha-lipoic acid complex protects the aging of myocardium by enhancing the Krebs cycle dehydrogenases and mitochondrial electron transport chain complexes (5). It increases the level of glutathione and reduces the level of lipid peroxidation (6)(7). Palladium-alpha-lipoic acid complex also protects against radiation-induced cellular damages in animals (4).